Laser treatments of the prostate vs. TURP/open prostatectomy: Systematic review of urodynamic data

Minerva Urologica e Nefrologica

Volumn 61, Issue 3, 2009, Pages 309-324

  Herrmann, T R W ^a   Georgiou, A ^a,b   Bach, T ^c,d   Gross, A J ^d   Oelke, M ^a,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Vardakeio and Proio General Hospital   (Greece)

^c ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^d UNIVERSITY OF MANNHEIM   (Germany)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HoLAP; HoLEP; Lasers; Prostatectomy; ThuLEP; Transurethral resection of prostate

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOLMIUM LASER; HUMAN; LASER SURGERY; MEDICAL LITERATURE; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE; URODYNAMICS; UROFLOWMETRY; VAPORIZATION; YAG LASER;

HUMANS; LASER COAGULATION; LASER THERAPY; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 74749101911     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Naslund MJ, Issa MM, Fenter TC. The prevalence, costs, and burden of enlarged prostate (EP) in men ?50 years of age [abstract 1345]. J Urol 2006;175(4 Suppl):433.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-9.
3. Hald T. Urodynamics in benign prostatic hyperplasia. A survey. Prostate Suppl 1989;2:69-77.
4. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547-54.
5. Hutchison A, Farmer R, Chapple C, Berges R, Pientka L, Teillac P et al. Characteristics of patients presenting with LUTS/BPH in six European countries. Eur Urol 2006;50:555-62.
6. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9.
7. Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol 2008;54:419-26.
8. Mamoulakis C, Trompetter M, de la Rosette JJ. Bipolar transurethral resection of the prostate: the "golden standard" reclaims its leading position. Curr Opin Urol 2009;19:26-32.
9. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P et al.; Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10 654 patients. J Urol 2008;180:246-9.
10. Oxford Centre for Evidence-Based Medicine. Levels of evidence and grades of recommendation. [accessed 2009 April; cited 2009 July 27). Available at: http://www.cebm.net/levels-of-evidence.asp.
11. Cowles RS III, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B et al. A prospective random-ized comparison of transurethral resection to visual laser ablation of the prostate for the treat-ment of benign prostatic hyperplasia. Urology 1995;46:155-60.
12. Suvakovic N, Hindmarsh JR. A step towards day case prostatectomy. Br J Urol 1996;77:212-4.
13. Gujral S, Abrams P, Donovan JL, Neal DE, Brookes ST, Chacko KN et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study. J Urol 2000;164:59-64.
14. McAllister WJ, Absalom MJ, Mir K, Shivde S, Anson K, Kirby RS et al. Does endoscopic laser ablation of the prostate stand the test of time? Five-year results from a multicentre ran-domized controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000;85:437-9.
15. Brookes S, Peters T, Campbell R, Featherstone K, Neal D, Abrams P et al. Including a 'no active intervention' arm in surgical trials is possible: evidence from the CLasP randomised trial. J Health Serv Res Policy 2003;8:209-14.
16. Planz B, Kalem T, Sprenger C, Deix T, Djavan B, Hanke P. A prospective randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone. Urol Int 2003;71:26-30.
17. Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003;169:210-5.
18. Muschter R. Free-beam and contact laser coagulation. J Endourol 2003;17:579-85.
19. Zorn BH, Bauer JJ, Ruiz HE, Thrasher JB. Randomized trial of safety and efficacy of tran-surethral resection of the prostate using contact laser versus electrocautery. Tech Urol 1999;5:198-201.
20. Keoghane SR, Lawrence KC, Gray AM, Doll HA, Hancock AM, Turner K et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 2000;85:74-8.
21. Tuhkanen K, Heino A, Aaltomaa S, la-Opas M. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates. Scand J Urol Nephrol 2003;37:487-93.
22. van Melick HH, van Venrooij GE, Eckhardt MD, Boon TA. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and elec-trovaporization in men with benign prostatic hyperplasia: urodynamic effects. J Urol 2002;168:1058-62.
23. Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999;13:127-30.
24. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004;172:616-9.
25. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol 2004;18:189-91.
26. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospec-tive trial in 200 patients. J Urol 2004;172:1012-6.
27. Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006;175:1817-21.
28. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int 2006;97:85-9.
29. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 2006;50:563-8.
30. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006;50:569-73.
31. Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004;172:1926-9.
32. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003;170:1270-4.
33. Tuhkanen K, Heino A, la-Opas M. Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign pros-tates. Scand J Urol Nephrol 2001;35:200-4.
34. Martenson AC, De La Rosette JJMC. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: Results of an evolving technology. Prostate Cancer Prostatic Dis 1999;2:148-54.
35. Norby B, Nielsen HV, Frimodt-Moller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002;90:853-62.
36. Kursh ED, Concepcion R, Chan S, Hudson P, Ratner M, Eyre R. Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 2003;61:573-8.
37. Kim TS, Choi S, Rhew HY, Ahn JH, Jang JH, Cho MH. [Comparative study on the treatment outcome and safety of TURP, ILC, TUNA and TEAP for patients with benign prostatic hyperplasia. Korean Journal of Urology 2006;47:13-9.
38. Liedberg F, Adell L, Hagberg G, Palmqvist I-B. Interstitial laser coagulation versus transure-thral resection of the prostate for benign prostatic enlargement: a prospective randomized study. Scand J Urol Nephrol 2003;37:494-7.
39. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5.
40. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70mL: a short-termprospective randomized trial. Urology 2008;71:247-51.
41. Tasci AI, Tugcu V, Sahin S, Zorluoglu F. Photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008:347-54.
42. Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann K-P, Braun PM. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 2008;54:902-10.
43. Ruszat R, Bachman A, Wyler S, Seifert HH, Forster T, Reich O, Sulser T. Photoselective vaporisation of the prostate (PVP): functional outcome and adverse events after 285 procedures. Eur Urol Suppl 2006;5:233.
44. Reddy B, Gouzales RR, Sandhu JS, Kaplan SA, Te AE. KTP photoselective vaporization of the prostate: New York Presbyterian-Cornell experience. SIU meeting on prostate disease, Bariloche Argentinia 2005;29.9-1.10.
45. Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999;83:254-9.
46. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002;60:305-8.
47. Abdel-Khalek M, El-Hammady. S, Ibrahiem el-H. A 4-year follow-up of a randomized prospective study comparing transurethral electrovaporization of the prostate with neodymium: YAG laser therapy for treating benign prostatic hyperplasia. BJU Int 2003;91: 801-5.
48. Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol 2007;25: 221-5.
49. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 2008;22: 1041-5.
50. Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008;53:382-9.
51. Bach T, Herrmann TR, Ganzer R, Gross AJ. RevoLixTM vaporesection of the prostate: Initial results after 54 patients with an one-year follow-up. World J Urol 2007;25:257-62.
52. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, GrossAJ. Thulium:YAG vaporesection of the prostate: first results. Urologe A 2009;48:529-34.
53. Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of prostate for patients in urinary retention. Urology 2005;66:789-93.
54. Peterson MD, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol 2005;174:998-1001.
55. Bach T, Herrmann TR, Haecker A, Michel MS, Gross A. Thulium:yttrium- aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 2009 [Epub ahead of print].
56. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ. Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol. 2009 Jan 28. [Epub ahead of print]
57. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-months-follow-up of a randomized study. J Endourol 2004;18:189-91.
58. Moody J, Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 2001;165:459-63.
59. Wilson LC, Gilling PJ. From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nature Clin Pract Urol 2005;2:443-8.
60. Pedraza R, Samadi A, Eshghi M. Holmium laser enucleationof the prostate in critically ill patients with technique modification. J Endourol 2004;18:795-8.
61. Elzayat EA, Elhilali MM. Experience of 603 cases treated with holmium laser enucleation of the prostate (HoLEP) for symptomatic benign prostatic hyperplasia. J Urol 2006;175:490.
62. Naspro R, Freschi M, Salonia A, Guazzoni G, di Givolamo V, Scattoni RCV et al. Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable? J Urol 2004;171:1203-6.
63. Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F et al. .A Review of the Recent Evidence (2006-2008) for 532-nm Photoselective Laser Vaporisation and Holmium Laser Enucleation of the Prostate. Eur Urol 2009 Apr [Epub ahead of print].
64. Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2 015 cases. J Urol 1962;87:450.
65. Melchior J, Valk WL, Foret JD, Mebust WK. Transurethral prostatectomy: computerized analysis of 2 223 consecutive cases. J Urol 1974;112:634.
66. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3 885 patients. J Urol 1989;141:243. 11.
67. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
68. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60.
69. Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 2006;175:1428-32.
70. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso JV, Manzarbeitia F, Sarasa-Corral JL, Granizo JJ. The impart of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int 2005;96:1045-8.
71. Montorsi F, Alcaraz A, Desgrandchamps F, Hammerer P, Schröder F, Castro R. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. Prostate 2009;69:895-907.
72. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALFONE. BJU Int 2008;101(Suppl 3):17-21.
73. Descazeaud A, Robert G, Azzousi AR, Ballereau C, Lukacs B, Haillot O et al.; French Association of Urology. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 2009;103:1162-5.
74. Parr NJ, Loh CS, Desmond AD. Transurethral resection of the prostate and bladder tumor without withdrawal of warfarin therapy. Br J Urol 1998;64:623-5.
75. Chakravarti A, MacDermott S. Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 1998;81:520-2.
76. Hemuann TR, Oleve M, Bach T, Stöhner M, Burchandt M, Gross AJ. Thullium enucleation of the prostate (ThuLEP). Transurethral anatomical prostatectomy. Introduction of a novel technique. World J Urol; submitted for publication.